Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the united states

American Journal of Gastroenterology

Volumn 108, Issue 3, 2013, Pages 444-449

  Wang, Yize R ^a,b,c   Cangemi, John R ^a   Loftus, Edward V ^a   Picco, Michael F ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Division of Gastroenterology and Liver Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; DATA BASE; EARLY CANCER; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; ULCERATIVE COLITIS; UNITED STATES;

AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; SEER PROGRAM; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 84875227467     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.429     Document Type: Article

References (38)

1. Gross CP, Andersen MS, Krumholz HM et al. Relationship between medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA 2006; 296: 2815-22.
2. Lieberman DA. Clinical practice: screening for colorectal cancer. N Engl J Med 2009; 361: 1179-87.
3. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009; 104: 739-50.
4. Pohl H, Robertson DJ. Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol 2010; 8: 858-64.
5. Rex DK, Rahmani EY, Haseman JH et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112: 17-23.
6. Bressler B, Paszat LF, Vinden C et al. Colonoscopic miss rates for rightsided colon cancer: a population-based analysis. Gastroenterology 2004; 127: 452-6.
7. Bressler B, Paszat LF, Chen Z et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007; 132: 96-102.
8. Singh H, Nugent Z, Mahmud SM et al. Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol 2010; 105: 663-73.
9. Singh H, Nugent Z, Demers AA et al. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol 2010; 105: 2588-96.
10. Ekbom A, Helmick C, Zack M et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-33.
11. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-35.
12. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002; 51 (Suppl 5): V10-2.
13. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale (update based on new evidence). Gastroenterology 2003; 124: 544-60.
14. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004; 99: 1371-85.
15. Eaden J. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20 (Suppl 4): 24-30.
16. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 314-21.
17. Jess T, Gamborg M, Matzen P et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005; 100: 2724-9.
18. Jess T, Loftus EV Jr, Velayos FS et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology 2006; 130: 1039-46.
19. Davila RE, Rajan E, Baron TH et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006; 63: 546-57.
20. Rubin DT, Kavitt RT. Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin North Am 2006; 35: 581-604.
21. Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol 2008; 14: 3937-47.
22. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105: 501-24.
23. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups. Gut 2010; 59: 666-89.
24. Winther KV, Jess T, Langholz E et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2004; 2: 1088-95.
25. Collins PD, Mpofu C, Watson AJ et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006; 2-CD000279.
26. Baars JE, Looman CWN, Steyerberg EW et al. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol 2011; 106: 319-28.
27. Gearry RB, Wakeman CJ, Barclay ML et al. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand. Dis Colon Rectum 2004; 47: 314-22.
28. van Rijn AF, Fockens P, Siersema PD et al. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in The Netherlands. World J Gastroenterol 2009; 15: 226-30.
29. Spiegel BM, Ho W, Esrailian E et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol 2009; 7: 168-74.
30. Velayos FS, Liu L, Lewis JD et al. Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system. Gastroenterology 2010; 139: 1511-8.
31. Warren JL, Klabunde CN, Schrag D et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40 (supplement): IV-3-IV-18.
32. Picco MF, Cangemi JR. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 2009; 38: 447-62.
33. Rabeneck L, Paszat L, Saskin R. Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastro Hep 2010; 8: 275-9.
34. Diamond SJ, Enestvedt BK, Jiang Z et al. Adenoma detection rate increases with each decade of life after 50 years of age. Gastrointest Endosc 2011; 74: 125-40.
35. Rutter M, Saunders B, Wilkinson K et al. Severity of infl ammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126: 451-9.
36. Rutter MD, Saunders BP, Wilkinson KH et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004; 53: 1813-6.
37. Herrinton LJ, Liu J, Lewis JD et al. Incidence and prevalence of inflammatory bowel disease in a northern California managed care organization, 1996: 2002. Am J Gastroenterol 2008; 103: 1998-2006.
38. Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-8.